Visits: 549, Avg visit time (secs): 151,41 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 213 | 38,80% | |
| /sanofi-aventis/executive.html | 52 | 9,47% |
| /sanofi-aventis/programmes.html | 35 | 6,38% |
| /sanofi-aventis/partners.html | 23 | 4,19% |
| /sanofi-aventis/micro_macro/s-a 10 rfa.html | 22 | 4,01% |
| /sanofi-aventis/recipients.html | 17 | 3,10% |
| /sanofi-aventis/endocannabinoid/efsd-sanofi-aventis-ecs-recipients.html | 16 | 2,91% |
| /sanofi-aventis/contact.html | 14 | 2,55% |
| /sanofi-aventis/reports.html | 12 | 2,19% |
| /lilly/contact.html | 11 | 2,00% |
| /sanofi-aventis/micro_macro/recipientsmicro_macro.html | 10 | 1,82% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 232 | 42,26% |
| /sanofi-aventis/executive.html | 42 | 7,65% |
| /home.html | 27 | 4,92% |
| /sanofi-aventis/partners.html | 26 | 4,74% |
| /sanofi-aventis/contact.html | 21 | 3,83% |
| /sanofi-aventis/programmes.html | 20 | 3,64% |
| /sanofi-aventis/macrovascular/efsd-sanofi-aventis-cvd-recipients.html | 19 | 3,46% |
| /sanofi-aventis/reports.html | 14 | 2,55% |
| /sanofi-aventis/reviewers.html | 11 | 2,00% |
| /sanofi-aventis/micro_macro/s-a 10 rfa.html | 9 | 1,64% |
| /sanofi-aventis/home.html | 9 | 1,64% |